Background: Neonatal sepsis remains a challenge for neonatal care providers.Aim: This work was aiming to measure red cell distribution width percent (RDW %) as a marker for neonatal sepsis and to correlate it with other indicators and with a simple clinical scoring system for neonatal sepsis (Griffin score).Methods: This case control study was carried out at neonatal intensive care unit at Fayoum University Hospital and Abshawai central hospital . Ethical Research Committee Approval and written consents were obtained from parents of the neonates30 neonatal sepsis cases and 30 normal controls. Neonates were subjected to: History taking, clinical examination for manifestations of sepsis. Complete blood count, differential leucocytic count, C-reactive protein, Blood culture, RBS, and determination of RDW % were done to all neonates.Results: Our study showed that I/T ratio and RBS was significantly higher in cases than controls (p<0.001), but WBCs show no statistically significant difference among cases and controls. Moreover, blood culture was positive in 63.3% of cases only. Also, CRP was high in 76.7% of cases and 30% of controls (P=0.01) , and that the mean RDW % was higher among cases than controls (16.4 ± 3.8 and 13.7± 1.6 respectively) (P = 0.001), with further increase in preterm neonates . Also, there was a significant positive correlation between RDW level Griffin score (p=0.001). However, there was insignificant difference between RDW and WBCs or I/T ratio but high RDW level associated with raised RBS level of study group.
Conclusion:RDW can serve as a marker and prognostic indicator in neonatal sepsis especially when used together with Griffin score.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.